>The side effect of the price hike was the insurance companies has to pay more, not individuals.
I keep seeing this, don't you realize that those increased insurance costs are passed on to the people paying for insurance?
>He raised the price of Daraprim in order to fund R&D to find alternative treatments as Daraprim caused some nasty side effects.
You shouldn't buy into his PR efforts, take a look at this:
Shkreli admitted his company sold the same form of pyrimethamine, or Daraprim, that had been on the market for 70 years — although he expressed hope that his company could develop a more potent form of the drug that did not hinder the body’s production of folic acid.
“The mechanism of the drug is folate inhibition,” Anandya reminded the CEO, adding that what Shkreli had proposed might not even be scientifically possible.
“The entire mechanism of the drug is to stop the production of folic acid in the first place and the bulk of its side effects are tied up with that,” Anandya said. “It’s kind of counter-intuitive to say that you are going to solve this problem when it’s not a problem as much as the whole raison d’etre of the drug. This I find is the main problem with your plan. That the solution is not worth $749.”
“One cannot suggest such a (monstrous) increase in the price of a drug which by your own admission does nothing better while telling me your plan is to (because this is the only way it would work) create an entirely new drug not related to pyrimethamine at all because it would require a new structure,” the physician continued. “Which in turn would give you a big hassle since you would require testing and FDA approval from scratch anyway. I think your plan is flawed.”
from: http://www.alternet.org/economy/pharma-bro-martin-shkreli-ge...